BB's resume is quite impressive. The guy running the book build at BP has been described as a gun. LTers believe in the product. 40 odd days after FDA approval I expect plenty to be going on behind closed doors.
We don't know who the SI is yet. The placement may have been strategic.
BB may yet prove to be a champion. Early days.
I'm keeping an open mind.
I expect strong support of the SP tomorrow in the event of any emotional selling. Plenty of holders looking to average down. You snooze, you lose. DYOR. GLTAH.
BB's resume is quite impressive. The guy running the book build...
-
- There are more pages in this discussion • 114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
